At the news
? NEUTRALIMPACT 5/10 8-K filed Nov 2, 2026 at 06:30 ET
Lazard completed its acquisition of Campbell Lutyens on November 1, 2026, issuing 9,651,777 shares of common stock (valued at $46.50 per share reference price) and approximately $93.2 million in cash as initial consideration, plus up to $115 million in deferred consideration and up to $85 million in earn-out consideration. The company also entered into a registration rights agreement with the sellers covering the resale of the shares issued as consideration, and filed an amendment to the purchase agreement with various pre-closing adjustments.
- Acquisition of Campbell Lutyens completed on November 1, 2026.
- Initial consideration: 9,651,777 shares of Lazard common stock (reference price $46.50/share) plus approximately $93.2 million in cash.
- Deferred consideration of $115 million payable on second anniversary of closing.
- Earn-out consideration of up to $85 million based on revenue-growth targets through 2030.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access